Diplomat Pharmacy Inc (DPLO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,360 | 6,040 | 84,251 | 27,152 | 7,804 |
| Receivables | 349,845 | 329,749 | 332,091 | 277,840 | 279,604 |
| Inventories | 170,175 | 194,755 | 206,603 | 194,958 | 178,131 |
| TOTAL | $545,392 | $543,954 | $634,070 | $509,271 | $476,016 |
| Non-Current Assets | |||||
| PPE Net | 38,838 | 39,719 | 38,990 | 20,575 | 20,963 |
| Intangibles | 1,194,268 | 1,210,634 | 1,224,635 | 577,736 | 553,278 |
| Other Non-Current Assets | 39,372 | 37,602 | 42,728 | 46,467 | 49,065 |
| TOTAL | $1,272,478 | $1,287,955 | $1,306,353 | $644,778 | $623,306 |
| Total Assets | $1,817,870 | $1,831,909 | $1,940,423 | $1,154,049 | $1,099,322 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 146,600 | 151,500 | 199,750 | 32,467 | 13,396 |
| Accounts payable and accrued liabilities | 409,226 | 425,217 | 413,463 | 327,504 | 307,718 |
| Accrued Expenses | 18,941 | 21,560 | 17,684 | 21,042 | 19,303 |
| Other current liabilities | 22,005 | N/A | 20,560 | N/A | N/A |
| TOTAL | $596,772 | $615,178 | $651,457 | $381,013 | $340,417 |
| Non-Current Liabilities | |||||
| Long Term Debt | 442,734 | 444,916 | 521,098 | 116,543 | 119,006 |
| Other Non-Current Liabilities | 7,377 | 4,000 | 4,024 | 9,355 | 4,466 |
| TOTAL | $463,626 | $462,736 | $539,465 | $125,843 | $123,371 |
| Total Liabilities | $1,060,398 | $1,077,914 | $1,190,922 | $506,856 | $463,788 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 74,407 | 74,133 | 74,069 | 68,873 | 68,303 |
| Common Shares | 625,354 | 621,853 | 619,235 | 525,172 | 515,820 |
| Retained earnings | 87,276 | 91,240 | 91,816 | 85,280 | 84,264 |
| Other shareholders' equity | -962 | 0 | 0 | 23 | 78 |
| TOTAL | $757,472 | $753,995 | $749,501 | $647,193 | $635,534 |
| Total Liabilities And Equity | $1,817,870 | $1,831,909 | $1,940,423 | $1,154,049 | $1,099,322 |